IPO Listed

Apnimed IPO

US$192m raised

Lodged 30 Jul 2026 · NASDAQ: APMD · US$16.00 cash per share

Advisers

Apnimed

Issuer

Legal adviser
Issuer
Apnimed
Issuer based in
United States
Listed
31 Jul 2026
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.